Indegene Shares Soar with Strong Debut on NSE and BSE

Indegene made a remarkable entry into the market today with its shares soaring on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). The Indegene share price opened at a significant premium, marking a strong debut.

The highly anticipated IPO of Indegene witnessed a subscription of nearly 70 times on its closing day. Qualified Institutional Buyers (QIBs) showed great interest with a subscription rate of almost 200 times, demonstrating the confidence in the company’s offering.

The price band for the Indegene IPO was set between ₹430 to ₹452 per equity share. The overwhelming response from investors reflected a strong demand for the healthcare technology company’s shares.

Key players such as Citigroup Global Markets, J.P. Morgan India, Nomura Financial Advisory, and Kotak Mahindra Capital were part of the book-running lead managers for the Indegene IPO, ensuring a smooth and successful offering.

Investorgain.com reported a grey market premium (GMP) of +307 for Indegene, indicating substantial investor interest in the shares even before the listing. The high GMP projected a positive listing for the company.

Indegene’s IPO also included an offer-for-sale (OFS) with major shareholders divesting equity shares. Notable entities such as CA Dawn Investments were part of the selling shareholders, contributing to the total offering in the IPO.